Navigation Links
Prospective in Biological Technology

HealthCore Responds to Need for Real-world Health Outcomes Information on Drugs and Devices with Physician Network and Prospective Effectiveness Research

... physicians who participate in real-world prospective effectiveness research - in response to ... of WellPoint, Inc., is focusing on real-world prospective effectiveness research for healthcare ... will facilitate and shorten the life-cycle of prospective effectiveness research and comparative ...

U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)

... in the current episode. After an eight-week prospective treatment phase with one ADT plus single- blind ... the mean change from baseline -- the end of the prospective treatment phase -- to the end of the ... * Inadequate response for prospective treatment was defined as less than 50 percent ...

First U.K. Stem Cell Awareness Rally to Take Place in Manchester, England on August 9th, 2009

... ) seventh awareness rally, past patients, interested physicians, and prospective patients will meet in Manchester to learn about stem cell technologies and ... stem cell patients have the opportunity to share their experiences with prospective patients. It will also provide an opportunity for doctors and medical ...

Colorado Stem Cell Awareness Rally to Take Place in Denver, Colorado on June 13th, 2009

... 13th, 2009. The group's last event, in Punta Gorda, Florida, drew past and prospective patients, news media, U.S. physicians and specialists, as well as members ... and Canada are provided the opportunity to share their experiences with prospective patients. It will also provide an opportunity for doctors and medical ...

Sigma-Aldrich Honored With CIO 100 Award for Innovative Web Research Tool, Your Favorite Gene powered by Ingenuity

... to dynamic gene-based content that they can use to model and evaluate prospective experiments in the context of previously published scientific literature. ... providing insight into pathway interactions. Users can also model prospective experiments in Your Favorite Gene powered by Ingenuity, which bases its ...

Amorcyte Reports Phase I Results of AMR-001 to Improve Recovery From Severe Heart Attack at ACC Annual Scientific Session

... effect. This summation of prior studies supports Amorcyte's subsequent prospective findings. "Having successfully confirmed a dose effect, Amorcyte looks forward to proceeding with a larger prospective randomized trial and furthering our clinical program with AMR-001," said ...

Agencies Unite to Launch Donor Network Alliance: First-Ever Web-Based Collective of Egg Donor Candidates

... A new Web site has launched that facilitates the search for egg donors by prospective parents undergoing alternative reproductive processes. The Donor Network ... the playing field, giving participating agencies exposure to far more prospective parents through a shared site than they'd see individually," she said. ...

Sigma-Aldrich Launches Your Favorite Gene Powered by Ingenuity

... site also provides researchers with the capability to model and evaluate prospective experiments in the context of previously published scientific literature. ... providing insight into pathway interactions. Researchers can also model prospective experiments in Your Favorite Gene powered by Ingenuity, accessing the ...

Kidneys for Transplant Function Earlier and Last Longer When Preserved in a Machine Compared to the Traditional Box of Ice

... box of ice (cold storage).(1) The study was the first randomised, prospective trial to compare these two methods of preservation. Depending on the ... factor for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with ...

Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association

... testing (Refer to ARUP test number 0040116). About the Studies In the prospective study called ICARE, 2,241 individuals with diabetes mellitus age 55 or ... of angioplasty, and of heart failure and death following a heart attack. prospective clinical trials have demonstrated that the rate of heart attack in Hp2-2 ...

Advanced Life Sciences Announces Second Quarter 2008 Financial Results

... pneumonia (CAP) indication; * Progressed negotiations with prospective partners for the commercialization of cethromycin; * Announced ... in the CAP indication to the FDA; * Advance negotiations with prospective partners for the commercialization of cethromycin; * Present ...

ARR Offers Parents 'Extended Choice' in Egg Donor Selections

... is right for them prior to making a selection. During that period, other prospective parents may view the donor's profile, but are precluded from choosing her ... for a limited pool of qualified donors," said Robin von Halle. "Once prospective parents find a donor who fits their criteria, they have to make the ...

Two Year Study Confirms SUPPRELIN(R) LA Implant Maintains Profound Suppression of Hormones in Children With Premature Onset Puberty

... precocious puberty." About the Study The study was a multi-center, prospective extension study following an initial 12 month Phase III trial. Thirty-one ... 14.98 at 12 months to 88.00 +/- 19.63 at 24 months (p=0.0389). Continued prospective follow up studies are needed to investigate long term effects of the ...

Endocare Reports 2008 First Quarter Financial Results

... force continues to report steady progress in its sales activities with prospective physician customers. We believe this is due in part to the continuing ... or V-Probe, technology has been received enthusiastically by existing and prospective physicians due in part to the potentially significant advantages that the ...

Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year

... and biostatistics experts had been convened to offer advice about the prospective analysis of the ENHANCE trial. (Announced Nov. 19, 2007) -- Reported ... and expected synergies related to the Organon BioSciences acquisition; prospective products or product approvals; trends in performance; anticipated timing ...

Berlin Heart Enrolls First Patient in US Multi-Center EXCOR(R) Pediatric VAD IDE Study

... -- Berlin Heart today announced the first patient enrolment in the prospective IDE study for its EXCOR(R) Paediatric VAD, a mechanical cardiac support ... The U.S. Food and Drug Administration granted conditional approval for the prospective IDE study to begin initially at 10 centers with 10 patients in May 2007. ...

ThermoGenesis Provides Update on Fiscal 2009 Results

... continue during 2010. Recent addition of the New England Cord Blood Bank as a customer for the AXP. The AXP is also being evaluated at other prospective sites which, if successful, is expected to generate additional revenues. Positive clinical response to the MXP. The Company intends to add ...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... passed as compared to existing competitive IVC filters. The Option IVC Filter was approved based upon the results of a United States multi-center prospective clinical trial. The purpose of the clinical trial was to evaluate the device's safety and efficacy in preventing pulmonary emboli, and to assess the ...

Human Genome Sciences Announces Closing of Public Offering

... regulation of products, the impact of future alliances or transactions and other risks described in the Company's filings with the SEC. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences ...

Global Jatropha Hi-Tech Agricultural Training Programme (JWTP)

... Training Programme shall be from October 6-10, 2009 in Rajasthan, India. Jatrophaworld Training Programme 2009 shall be a sole solution to all prospective stakeholders to know the Jatropha in real form from Plant science to Plant technology. JWTP is unique because of the capability to deliver an ...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

... Our agreement with Purdue establishes the potential for a substantial Transcept revenue stream, and now enables us to focus increasing attention on prospective Intermezzo ((R) )commercialization partners in other parts of the world. The increased resources Transcept receives from this collaboration will ...

Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies

... generated interest from many leading oil companies, lubricant additive manufactures and automakers, and is currently open to applications from prospective members in advance of its first meeting of interested parties in October 2009. Companies wishing to register an interest in participating or obtain ...

Human Genome Sciences Announces Pricing of Public Offering of Common Stock

... regulation of products, the impact of future alliances or transactions and other risks described in the Company's filings with the SEC. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences ...

Human Genome Sciences Announces Proposed Public Offering of Common Stock

... regulation of products, the impact of future alliances or transactions and other risks described in the Company's filings with the SEC. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences ...

Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government

... associated with the raxibacumab contract, future revenues from the sale of raxibacumab to the U.S. Government will not occur. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences ...

Schering-Plough Reports Financial Results for 2009 Second Quarter

... plans; its strategies; business prospects; anticipated growth; timing and level of savings achieved from the Productivity Transformation Program; prospective products or product approvals; trends in performance; anticipated timing of clinical trials and its impact on R&D spending; anticipated ...

avVaa World Health Care Products Inc. Announces Web Site Design for Neuroskin(R) Psoriasis Relief DRTV Campaign

... for the Neuroskin(R) campaign. The new site will include an up-to-date look and feel, customer friendly navigation, and areas where customers and prospective customers can ask questions and interact. Lorie Campbell-Farley, President/COO of avvaa commented by saying, "our sales and marketing division at ...

Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax

... meet requirements associated with the ABthrax contract, future revenues from the sale of ABthrax to the U.S. Government will not occur. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences ...

Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus

... meet requirements associated with the ABthrax contract, future revenues from the sale of ABthrax to the U.S. Government will not occur. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences ...

Sigma-Aldrich and Atlas Antibodies Announce 2,300 New, Highly Validated Prestige Antibodies(RM)

... Antibodies are ideal for a number of applications, and with our unique online tools we help scientists figure out how to best incorporate them into prospective experiments." Prestige Antibodies are supported by the publicly available data of the Human Protein Atlas (HPA), part of HUPO's Human Antibody ...

Human Genome Sciences Announces Completion of Enrollment in Phase 2b Monthly-Dosing Trial of Albuferon(R)

... meet requirements associated with the ABthrax contract, future revenues from the sale of ABthrax to the U.S. Government will not occur. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences ...

Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO

... by other companies; and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. ...

Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus

... meet requirements associated with the ABthrax contract, future revenues from the sale of ABthrax to the U.S. Government will not occur. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences ...

PROSTVAC(TM) Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late-Stage Prostate Cancer

... principal investigator of the study. The more detailed analysis supports the headline data that were reported in October 2008. In the Phase 2 prospective randomized placebo-controlled study of 125 patients with advanced prostate cancer, patients in the PROSTVAC(TM) group had a significantly longer ...

Jatrophaworld Training 2009: 2nd Generation nonfood Biofuel crops Knowledge Platform

... Training Programme shall be from July-21-25, 2009 in Rajasthan, India. Jatrophaworld Training Programme 2009 shall be a sole solution to all prospective stakeholders to know the Jatropha in real form from Plant science to Plant technology. JWTP is unique because of the capability to deliver an ...

LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting

... correction surgeons in their local area in the United States. To accomplish this, Trusted LASIK Surgeons uses a unique screening process where each prospective LASIK eye surgeon must meet the minimum required qualifications set by Trusted LASIK Surgeons. These qualifications for these doctors are based on ...

Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R)

... - a Multi-Center Experience Using SpyGlass (Poster Presentation) A poster presentation reports the results of a prospective 297- patient, 15-center registry that studied the utility and performance of the SpyGlass System for peroral cholangioscopy ....

Atherotech Receives Patent for ApoB Measurement

... (bad) lipoproteins present in blood circulation, and elevated apoB values represent increased risk for heart disease. In numerous well-designed prospective studies, apoB has been shown to be superior to LDL cholesterol in predicting cardiovascular events and in following the progression of heart disease. ...

ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week

... Mode of Action MOUNTAIN VIEW, Calif., May 19 /PRNewswire/ -- ChemoCentryx, Inc., today announced that data from the company's PROTECT-1 (the prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) Phase II/III clinical trial of Traficet-EN(TM) (CCX282-B) in patients with ...

Beckman Coulter Prices $500 Million Senior Notes Offering

... these securities will be made only by means of a prospectus and related prospectus supplements. When available, copies of the prospectus and related prospective supplements may be obtained by calling Citigroup Global Markets Inc. toll-free at 1-877-858-5407, by mailing J.P. Morgan Securities Inc., Investment ...
Other Contents
(Date:7/10/2014)... , June 27, 2014  The American Academy ... Institute of Standards and Technology (NIST) and the ... academic research and forensic science expert members to ... is an element of the NIST,s Organization of ... among the first appointments made to the new ...
(Date:7/10/2014)... N.Y. , July 2, 2014 It ... (ABD) to announce the appointment of the world-renowned Thoracic ... Board of Directors. Dr. Ginsburg, with over ... facilities: NY Presbyterian Hospital and Good Samaritan Regional Medical ... Pacemaker since the late 1980,s and is considered an ...
(Date:7/10/2014)... 7, 2014 According to a ... Access Control Systems Market Global Forecast, Market Share, Size, ... Electronic Access Control systems market was valued at USD ... at a CAGR of 12.6% from 2014 to 2019, ... in 2019. Browse the full Electronic Access ...
Breaking Biology News(10 mins):Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 3Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 2Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 3Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 4Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 5
(Date:7/10/2014)... THURSDAY, July 10, 2014 (HealthDay News) -- Men who ... aggressive prostate cancer, a new study suggests. But ... several urologists not involved with the study said more ... are truly accurate. For the study, Harvard researchers ... were followed for 24 years, starting in 1986. During ...
(Date:7/10/2014)... Service (EMS) responders felt better prepared to respond to ... according to a new study in the journal ... study to specifically examine the EMS provider comfort level ... has not yet been neutralized or working with law ... the Columbine High School shooting, the Virginia Tech campus ...
(Date:7/10/2014)... top public health concerns in the United States, with ... as of 2012. As health problems such as childhood ... to discuss the problem. , A new study, led ... Brown School at Washington University in St. Louis, examined ... track Twitter conversations about the issue of overweight kids. ...
(Date:7/10/2014)... Up to 70% of Parkinson,s disease (PD) ... quality of life. Some patients have disturbed sleep/wake ... asleep, while other patients may be subject to ... extreme, PD patients may exhibit REM-sleep behavior disorder ... re-enactment, even before motor symptoms appear. A review ...
(Date:7/10/2014)... the clinical indicators most strongly associated with concussion is ... evidence-based guidelines for concussion diagnosis, prognosis, and treatment, according ... , official journal of the Congress ... Lippincott Williams & Wilkins , a part of ... on analysis of the best available research data, a ...
Breaking Medicine News(10 mins):Health News:Study Links Vasectomy to Aggressive Prostate Cancer 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 3Health News:Active shooter training increases comfort level of emergency responders 2Health News:Study looks at how Twitter can be used to address specific health issues 2Health News:Sleep disturbances, common in Parkinson's disease, can be early indicator of disease onset 2Health News:What's a concussion? Review identifies four evidence-based indicators 2Health News:What's a concussion? Review identifies four evidence-based indicators 3
Other TagsOther Tags